Menü
You have to log in or sign up before you can proceed.
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

AMN Healthcare Announces Second Quarter 2021 Results
AMN Healthcare Announces Second Quarter 2021 Results


AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced its second quarter 2021

Sangamo Therapeutics Reports Recent Business Highlights and Second Quarter 2021 Financial Results: https://mms.businesswire.com/media/20191101005100/en/736004/5/Sangamo_logoTM.jpg
Sangamo Therapeutics Reports Recent Business Highlights and Second Quarter 2021 Financial Results


Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today reported recent business highlights and second quarter 2021 financial results.



“This is an exciting time at Sangamo

Quidel Reports Second Quarter 2021 Financial Results
Quidel Reports Second Quarter 2021 Financial Results


Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today financial results for the

Lutheran Health Network of Indiana, LLC and Acadia Healthcare Hold Groundbreaking Ceremony for New Behavioral Health Hospital in Fort Wayne
Lutheran Health Network of Indiana, LLC and Acadia Healthcare Hold Groundbreaking Ceremony for New Behavioral Health Hospital in Fort Wayne


Lutheran Health Network of Indiana, LLC and Acadia Healthcare Company today held a groundbreaking ceremony for Maple Heights Behavioral Health, a new 120-bed inpatient behavioral health facility in

PAVmed to Present at the 41st Annual Canaccord Genuity Growth Conference
PAVmed to Present at the 41st Annual Canaccord Genuity Growth Conference


PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical technology company, today announced that Lishan Aklog, M.D., PAVmed’s

Vifor Pharma reports strong H1 2021 growth, on track to meet full year guidance1 : https://mms.businesswire.com/media/20191103005014/en/691947/5/VP_logo_rgb.jpg
Vifor Pharma reports strong H1 2021 growth, on track to meet full year guidance1


Regulatory News:



Vifor Pharma Group reported profitable revenue growth in H1 supported by a strong recovery in Ferinject® / Injectafer® with sales up 22.8% at CER as a result of improved patient

Vifor Pharma erzielt im 1. Halbjahr 2021 starkes Wachstum und bestätigt Jahresprognose1 : https://mms.businesswire.com/media/20191103005014/en/691947/5/VP_logo_rgb.jpg
Vifor Pharma erzielt im 1. Halbjahr 2021 starkes Wachstum und bestätigt Jahresprognose1


Regulatory News:



Die Vifor Pharma Gruppe erzielte im 1. Halbjahr 2021 ein profitables Umsatzwachstum dank einer starken Erholung von Ferinject®/Injectafer® mit einem Umsatzplus von 22.8% zu kWk

Xencor Reports Second Quarter 2021 Financial Results: https://mms.businesswire.com/media/20191105006084/en/713581/5/Xencor_RGB_fullcolor.jpg
Xencor Reports Second Quarter 2021 Financial Results


Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases, today reported

STAAR Surgical Reports Record Second Quarter Net Sales of $62.4 Million Up 77% Y/Y and Increases Outlook for 2021: https://mms.businesswire.com/media/20200413005098/en/683092/5/STAAR_Surgical_Logo_Primary_Lockup_%28Sunise_Teal%29.jpg
STAAR Surgical Reports Record Second Quarter Net Sales of $62.4 Million Up 77% Y/Y and Increases Outlook for 2021


STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today reported financial results for the

NanoString Releases Operating Results for Second Quarter of 2021: https://mms.businesswire.com/media/20191104005218/en/753909/5/NSTG-Logo-19-%28002%29.jpg
NanoString Releases Operating Results for Second Quarter of 2021


NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported financial results for the second quarter ended June

Hanger Reports Second Quarter 2021 Financial Results
Hanger Reports Second Quarter 2021 Financial Results


Hanger, Inc. (NYSE: HNGR), a leading provider of orthotic and prosthetic (O&P) patient care services and solutions, today announced its financial results for the second quarter and six months ended

Humana Highlights Commitment to Addressing Health Equity in 2020 Corporate Responsibility Report: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24514/Humana_logo.png
Humana Highlights Commitment to Addressing Health Equity in 2020 Corporate Responsibility Report


Humana Inc. (NYSE: HUM), one of the nation’s leading health and well-being companies, today released its 2020 Corporate Social Responsibility (CSR) report. As outlined in the report, Humana details

Agilent Earns 2021 Great Place to Work Certification in the U.S.:
Agilent Earns 2021 Great Place to Work Certification in the U.S.


Agilent Technologies Inc. (NYSE: A) today announced that it has been certified as a Great Place to Work in the U.S., a prestigious independent recognition based entirely on employee feedback about

NMPA’s Center for Drug Evaluation Adds Licenses of GastroPlus®: https://mms.businesswire.com/media/20200318005128/en/780378/5/BusinessWireLogo.jpg
NMPA’s Center for Drug Evaluation Adds Licenses of GastroPlus®


Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemical, and consumer goods industries, today announced that it

Clovis Oncology Announces Second Quarter 2021 Operating Results: https://mms.businesswire.com/media/20191107005162/en/305545/5/Clovis_Logo_Process_Color.jpg
Clovis Oncology Announces Second Quarter 2021 Operating Results


Clovis Oncology, Inc. (NASDAQ:CLVS) reported financial results for the quarter ended June 30, 2021, and provided an update on the Company’s clinical development programs and regulatory and

IMV Announces CEO Transition: https://mms.businesswire.com/media/20200225005324/en/775456/5/IMV_Logos_IMV-Logo_BrandStatement.jpg
IMV Announces CEO Transition


IMV Inc. (Nasdaq:IMV; TSX:IMV) (“IMV” or the “Company”), a clinical-stage biopharmaceutical company pioneering a novel class of cancer immunotherapies, today announced that Frederic Ors has stepped

Charles River Laboratories Announces Second-Quarter 2021 Results: https://mms.businesswire.com/media/20191106005189/en/754630/5/charles_river_logo.jpg
Charles River Laboratories Announces Second-Quarter 2021 Results


Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the second quarter of 2021. For the quarter, revenue was $914.6 million, an increase of 34.0% from $682.6

Pfizer Announces Positive Top-Line Results from Phase 2b/3 Trial of Ritlecitinib in Alopecia Areatahttp://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo
Pfizer Announces Positive Top-Line Results from Phase 2b/3 Trial of Ritlecitinib in Alopecia Areata


Pfizer Inc. (NYSE: PFE) today announced positive top-line results from the Phase 2b/3 ALLEGRO trial evaluating oral once-daily ritlecitinib in patients with alopecia areata, an autoimmune disease

LivaNova Prices Offering of Ordinary Shares: https://mms.businesswire.com/media/20191101005329/en/555341/5/LN-Logo-Main-PANTONE.jpg
LivaNova Prices Offering of Ordinary Shares


LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced that it has priced an underwritten offering of 3,636,364 ordinary shares at a price to the

Deciphera Pharmaceuticals, Inc. Announces Second Quarter 2021 Financial Results
Deciphera Pharmaceuticals, Inc. Announces Second Quarter 2021 Financial Results


Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) today announced financial results for the first quarter ended June 30, 2021 and provided a corporate update.



“We made significant progress against

Global Industry Executive Aster Angagaw Joins PAVmed Subsidiary Lucid Diagnostics’ Board of Directors
Global Industry Executive Aster Angagaw Joins PAVmed Subsidiary Lucid Diagnostics’ Board of Directors


PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical technology company, today announced that prominent global industry

Agilent Announces Target Enrichment Manufacturing Facility in China:
Agilent Announces Target Enrichment Manufacturing Facility in China


Agilent Technologies Inc. (NYSE: A) today announced that is has established in-country manufacturing for its SureSelect portfolio at its facility in Hangzhou, China.



Agilent is a leading provider

Premier Inc. to Participate in KeyBanc Capital Markets Virtual Technology Leadership Forum on August 10, 2021: https://mms.businesswire.com/media/20191105005372/en/754182/5/PR_LogoSpec_%282%29.jpg
Premier Inc. to Participate in KeyBanc Capital Markets Virtual Technology Leadership Forum on August 10, 2021


Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, announced today that members of its management team are scheduled to participate in a fireside chat at the KeyBanc Capital

LivaNova Announces Offering of Ordinary Shares: https://mms.businesswire.com/media/20191101005329/en/555341/5/LN-Logo-Main-PANTONE.jpg
LivaNova Announces Offering of Ordinary Shares


LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced it has commenced an underwritten offering of $300 million of its ordinary shares. LivaNova

Acadia Healthcare Reports Second Quarter 2021 Results and Increases 2021 Guidance: https://mms.businesswire.com/media/20200504005676/en/583255/5/ACHC.jpg
Acadia Healthcare Reports Second Quarter 2021 Results and Increases 2021 Guidance


Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced financial results for the second quarter ended June 30, 2021.



Second Quarter 2021 Results



The Company reported revenue of $582.2